Saddle-Reset for Robust Parameter Estimation and Identifiability Analysis of Nonlinear Mixed Effects Models
暂无分享,去创建一个
[1] R. Fletcher,et al. A modified Newton method for minimization , 1977 .
[2] L. Aarons,et al. What do we mean by identifiability in mixed effects models? , 2015, Journal of Pharmacokinetics and Pharmacodynamics.
[3] Danny C. Sorensen,et al. On the use of directions of negative curvature in a modified newton method , 1979, Math. Program..
[4] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.
[5] Leon Aarons. The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.
[6] Preconditioning of Nonlinear Mixed Effects Models for Stabilisation of Variance-Covariance Matrix Computations , 2016, The AAPS Journal.
[7] V. K. Siripuram,et al. Deterministic identifiability of population pharmacokinetic and pharmacokinetic–pharmacodynamic models , 2017, Journal of Pharmacokinetics and Pharmacodynamics.
[8] R. Gomeni,et al. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. , 1995, Journal of biopharmaceutical statistics.
[9] W. Vach,et al. Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer , 2011, The Pharmacogenomics Journal.
[10] R. Fletcher. Practical Methods of Optimization , 1988 .
[11] M. Karlsson,et al. Population Pharmacokinetic Modelling and Estimation of Dosing Strategy for NXY-059, a Nitrone Being Developed for Stroke , 2005, Clinical pharmacokinetics.
[12] Neil D. Evans,et al. Parameter Identifiability of Fundamental Pharmacodynamic Models , 2016, Front. Physiol..
[13] D. Bates,et al. Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .
[14] J F Boisvieux,et al. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.
[15] Roger Fletcher,et al. Practical methods of optimization; (2nd ed.) , 1987 .
[16] Claudio Cobelli,et al. A Priori Identifiability Analysis in Pharmacokinetic Experiment Design , 1981 .
[17] S. S. Wilks. The Large-Sample Distribution of the Likelihood Ratio for Testing Composite Hypotheses , 1938 .
[18] A Racine-Poon,et al. A Bayesian approach to nonlinear random effects models. , 1985, Biometrics.
[19] Arild Thowsen,et al. Structural identifiability , 1977, 1977 IEEE Conference on Decision and Control including the 16th Symposium on Adaptive Processes and A Special Symposium on Fuzzy Set Theory and Applications.
[20] R J Keizer,et al. Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose , 2013, CPT: pharmacometrics & systems pharmacology.
[21] Mats O Karlsson,et al. Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis. , 2004, British journal of clinical pharmacology.
[22] Marie Davidian,et al. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine , 1992, Journal of Pharmacokinetics and Biopharmaceutics.
[23] T H Grasela,et al. Neonatal population pharmacokinetics of phenobarbital derived from routine clinical data. , 1985, Developmental pharmacology and therapeutics.
[24] Robert J. Bauer,et al. Monte Carlo Parametric Expectation Maximization (MC-PEM) Method for Analyzing Population Pharmacokinetic/Pharmacodynamic Data , 2004 .
[25] V Shivva,et al. An Approach for Identifiability of Population Pharmacokinetic–Pharmacodynamic Models , 2013, CPT: pharmacometrics & systems pharmacology.
[26] Tim Hesterberg,et al. Introduction to Stochastic Search and Optimization: Estimation, Simulation, and Control , 2004, Technometrics.
[27] David J. Spiegelhalter,et al. Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[28] Robert J. Bauer,et al. A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples , 2007, The AAPS Journal.
[29] M. J. D. Powell,et al. Nonlinear Programming—Sequential Unconstrained Minimization Techniques , 1969 .
[30] Alexander H. G. Rinnooy Kan,et al. A stochastic method for global optimization , 1982, Math. Program..
[31] V. Carey,et al. Mixed-Effects Models in S and S-Plus , 2001 .
[32] F Mentré,et al. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics. , 1988, Biometrics.